Melanotan-2 calculators

A 10 mg Melanotan-2 vial mixed with 2 mL of bacteriostatic water gives 5 mg/mL — a relatively concentrated solution that keeps unit counts readable across the loading-then-maintenance arc. A 0.5 mg dose pulls 10 units.

One Melanotan-2-specific failure mode worth knowing before you use the reconstitution math: Not writing the reconstitution date on the vial. What is the relationship between Melanotan-2 and PT-141 (bremelanotide)? PT-141, also known as bremelanotide, is an active metabolite of Melanotan-2. It is a smaller peptide fragment corresponding to the core sequence of Melanotan-2 but lacks the specific amino acid residues that confer high affinity for the MC1 receptor. As a result, PT-141 is a more selective agonist, primarily targeting the MC3 and MC4 receptors. This difference in receptor targeting is why PT-141 is studied for effects related to sexual function and appetite, largely separate from the pigmentation effects associated with MC1R activation.

Vial size, diluent volume, and dose are the three inputs that genuinely change the answer. Doses-per-vial is a derived output — it's the vial mg divided by the dose mg, rounded down. The most common edge case is a tiny dose: at very high concentration, a 0.1 mL draw is only a few units on the syringe, which is hard to read accurately. If your unit count drops below five, consider reconstituting the next vial with more BAC water so each dose covers a larger volume.

The illustrative example on this page assumes a 10 mg vial reconstituted with 2 mL of bacteriostatic water — concentration of 5 mg per mL. A 0.5 mg illustrative dose is 0.1 mL or 10 units on a U-100 syringe.

Many users prefer 3 or 4 mL of diluent on a 10 mg vial to produce cleaner per-dose unit counts. The calculator handles any combination.

The small dose magnitudes often documented during a Melanotan-2 loading phase introduce a potential for measurement imprecision. For example, if a 10 mg vial is reconstituted with 2 mL of diluent to yield a standard concentration of 5 mg/mL, a typical loading dose of 0.25 mg would be only 0.05 mL, or 5 units on a U-100 insulin syringe. An even smaller dose of 0.1 mg would equate to just 0.02 mL, or a scant 2 units. Such small volumes are at the lower boundary of what can be accurately and consistently drawn with standard syringes, increasing the risk of measurement error and impacting the integrity of dose-tracking data.

To address this measurement challenge, a frequent workflow adjustment involves reconstituting the peptide with a greater volume of diluent to decrease its final concentration. For instance, reconstituting the same 10 mg vial with 4 mL of diluent would produce a concentration of 2.5 mg/mL. At this lower concentration, a 0.25 mg dose now corresponds to a much more manageable 0.1 mL, or 10 units on a U-100 syringe. This greater volume is easier to see and measure accurately, reducing the margin of error. It is vital to document the exact diluent volume used so that all dose calculations accurately reflect the intended milligram amount.